229 related articles for article (PubMed ID: 20974822)
1. Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice.
Eaton KA; Honkala A; Auchtung TA; Britton RA
Infect Immun; 2011 Jan; 79(1):185-91. PubMed ID: 20974822
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice.
Eaton KA; Friedman DI; Francis GJ; Tyler JS; Young VB; Haeger J; Abu-Ali G; Whittam TS
Infect Immun; 2008 Jul; 76(7):3054-63. PubMed ID: 18443087
[TBL] [Abstract][Full Text] [Related]
3. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.
Spinler JK; Taweechotipatr M; Rognerud CL; Ou CN; Tumwasorn S; Versalovic J
Anaerobe; 2008 Jun; 14(3):166-71. PubMed ID: 18396068
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus reuteri suppresses E. coli O157:H7 in bovine ruminal fluid: Toward a pre-slaughter strategy to improve food safety?
Bertin Y; Habouzit C; Dunière L; Laurier M; Durand A; Duchez D; Segura A; Thévenot-Sergentet D; Baruzzi F; Chaucheyras-Durand F; Forano E
PLoS One; 2017; 12(11):e0187229. PubMed ID: 29091926
[TBL] [Abstract][Full Text] [Related]
6. Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer's patches.
Thévenot J; Cordonnier C; Rougeron A; Le Goff O; Nguyen HT; Denis S; Alric M; Livrelli V; Blanquet-Diot S
Appl Microbiol Biotechnol; 2015 Nov; 99(21):9097-110. PubMed ID: 26084888
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of Colitis in Germ-Free Mice Infected With EHEC O157:H7.
Eaton KA; Fontaine C; Friedman DI; Conti N; Alteri CJ
Vet Pathol; 2017 Jul; 54(4):710-719. PubMed ID: 28178427
[TBL] [Abstract][Full Text] [Related]
8. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
[TBL] [Abstract][Full Text] [Related]
9. Effects of Lactobacillus kefiranofaciens M1 isolated from kefir grains on enterohemorrhagic Escherichia coli infection using mouse and intestinal cell models.
Chen YP; Lee TY; Hong WS; Hsieh HH; Chen MJ
J Dairy Sci; 2013; 96(12):7467-77. PubMed ID: 24140320
[TBL] [Abstract][Full Text] [Related]
10. Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection.
Garcia-Angulo VA; Kalita A; Torres AG
Vaccine; 2013 Jul; 31(32):3229-35. PubMed ID: 23707170
[TBL] [Abstract][Full Text] [Related]
11. Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice.
Gu J; Liu Y; Yu S; Wang H; Wang Q; Yi Y; Zhu F; Yu XJ; Zou Q; Mao X
Microbes Infect; 2009 Sep; 11(10-11):835-41. PubMed ID: 19427397
[TBL] [Abstract][Full Text] [Related]
12. Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7.
Sanchez-Villamil JI; Tapia D; Torres AG
mBio; 2019 Aug; 10(4):. PubMed ID: 31409688
[TBL] [Abstract][Full Text] [Related]
13. Detection of Enterohemorrhagic Escherichia Coli Colonization in Murine Host by Non-invasive In Vivo Bioluminescence System.
Kuo CJ; Wang ST; Chen CS
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29683443
[TBL] [Abstract][Full Text] [Related]
14. Prevention of enteric bacterial infections and modulation of gut microbiota with conjugated linoleic acids producing
Peng M; Tabashsum Z; Patel P; Bernhardt C; Biswas C; Meng J; Biswas D
Gut Microbes; 2020 May; 11(3):433-452. PubMed ID: 31411526
[TBL] [Abstract][Full Text] [Related]
15. Enterohemorrhagic Escherichia coli induce attaching and effacing lesions and hemorrhagic colitis in human and bovine intestinal xenograft models.
Golan L; Gonen E; Yagel S; Rosenshine I; Shpigel NY
Dis Model Mech; 2011 Jan; 4(1):86-94. PubMed ID: 20959635
[TBL] [Abstract][Full Text] [Related]
16. Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B.
Zhu C; Yu J; Yang Z; Davis K; Rios H; Wang B; Glenn G; Boedeker EC
Clin Vaccine Immunol; 2008 Feb; 15(2):359-66. PubMed ID: 18003816
[TBL] [Abstract][Full Text] [Related]
17. Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.
Bentancor LV; Mejías MP; Pinto A; Bilen MF; Meiss R; Rodriguez-Galán MC; Baez N; Pedrotti LP; Goldstein J; Ghiringhelli PD; Palermo MS
mBio; 2013 Oct; 4(5):e00501-13. PubMed ID: 24085779
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of Enterohemorrhagic Escherichia coli (EHEC) strains in patients with gastrointestinal disorders and patients with hemolytic uremic syndrome].
Med Dosw Mikrobiol; 2014; 66(3-4):161-75. PubMed ID: 25804070
[TBL] [Abstract][Full Text] [Related]
19. Impact of Lactobacillus-originated metabolites on enterohemorrhagic E. coli in rumen fluid.
Aditya A; Rahaman SO; Biswas D
FEMS Microbiol Ecol; 2022 Nov; 98(12):. PubMed ID: 36331030
[TBL] [Abstract][Full Text] [Related]
20. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].
Allerberger F; Sölder B; Caprioli A; Karch H
Wien Klin Wochenschr; 1997 Sep; 109(17):669-77. PubMed ID: 9381722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
